Sarepta Therapeutics (SRPT) U.K.-Specific Hold Concerns 'Overblown' - William Blair
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures slip as yields and oil rebound; Fed minutes in focusĀ
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Caribou Biosciences to halt CAR-T programs, explore sale
- Stryker names Spencer Stiles as CEO, Lobo moves to chair
- Francis Halzen wins Nobel physics prize for Antarctic 'ghost particle' hunt
Form SC 13G/A Sarepta Therapeutics, Filed by: SUSQUEHANNA SECURITIES
February 9, 2018 11:41 AM EST
SECURITIES AND EXCHANGE COMMISSION
... MoreForm SC 13G Sarepta Therapeutics, Filed by: FMR LLC
February 9, 2018 9:46 AM ESTSCHEDULE 13G Amendment No. 0 SAREPTA THERAPEUTICS INC COMMON STOCK Cusip #803607100 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #803607100 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,870,066 Item 6: 0 Item 7: 5,568,006 Item 8: 0 Item 9: 5,568,006 Item 11: 8.604% Item 12: HC Cusip #803607100 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 5,568,006 Item 8: 0 Item 9: 5,568,006 Item 11: 8.604% Item 12: IN Item 1(a). Name of Issuer: SAREPTA THERAPEUTICS INC Item 1(b). Address of Issuer's Principal Executive Offices: 215 FIRST STREET SUITE 415 CAMBRIDGE, MA 02142... More



